FiercePharma  9 hrs ago  Comment 
The Obama administration is already working with nursing homes to reduce inappropriate use of antipsychotic meds such as Seroquel, Risperdal and Zyprexa. But federal investigators now say officials need to focus on overuse in dementia patients.
Market Intelligence Center  Feb 25  Comment 
MarketIntelligenceCenter.com’s patented option-trade picking algorithm found two trade ideas on Eli Lilly and Co (LLY) today after it traded between between $70.51 and $71.50 before closing at $70.90 on Tuesday. For more conservative investors,...
FierceBiotech  Feb 24  Comment 
Everybody sees something different when they look at Eli Lilly, which has recently dropped out of the top 10 pharma group. A number of analysts, some with good reason to shine up to CEO John Lechleiter, see a company that has hit bottom and is on...
Financial Times  Feb 24  Comment 
Strict laws in the home state of its biggest investor prevent a hostile takeover
Benzinga  Feb 23  Comment 
In a report published Monday, Tigress Financial Partners analyst Philip Van Deusen maintained a Buy rating on Eli Lilly and Company (NYSE: LLY). "LLY is successfully transitioning its drug portfolio to mitigate the effects of generic...
FierceBiotech  Feb 23  Comment 
Eli Lilly's already-delayed new insulin has run into another roadblock, as potentially harmful liver side effects have sent the company back to the clinic, putting off a potential regulatory filing by a year or more and leading a top analyst to...
Jutia Group  Feb 23  Comment 
[Reuters] - Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter. The delay stems from a need to generate additional ... Read more on this. Eli Lilly...
FierceBiotech  Feb 20  Comment 
Cerecor acquired the rights to an Eli Lilly antidepressant, planning to take the drug into Phase II as a treatment for addictive disorders. 
Wall Street Journal  Feb 19  Comment 
Eli Lilly said it would extend a Phase 3 trial of its investigational treatment for high-risk cases of atherosclerotic cardiovascular disease.
Jutia Group  Feb 11  Comment 
[PR Newswire] - The stress of freshman year can be multiplied when the student is managing a chronic disease such as type 1 diabetes. To help ease the burden, Lilly Diabetes today announced the fulfillment of its two-year, $200,000 commitment...


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki